APPLICATION
ANDA208709
TYPE
ANDA
ORIGINAL APPROVAL
2016-12-15
LATEST ACTION
2025-08-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
FENOFIBRATEPrescription
FENOFIBRATE 48MG · TABLET · ORAL
FENOFIBRATEPrescription
FENOFIBRATE 145MG · TABLET · ORAL
Approval history
2025-08-21Labeling · Supplement 11 · standardAP
2022-05-27Labeling · Supplement 6 · standardAP
2019-09-19Labeling · Supplement 5 · standardAP
2019-09-19Labeling · Supplement 3 · standardAP
2019-09-19Labeling · Supplement 2 · standardAP
2016-12-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.